fbpx

< Back to Thought Leadership

Blue & Co., LLC Ranked No. 60 in IPA’s 2019 Top 100 Firms

CARMEL, Ind. (August 15, 2019) – Blue & Co., LLC is pleased to announce that it was ranked as no. 60 in IPA’s 2019 Top 100 Firms, moving up one spot from the previous year.

About IPA’s 2019 Top 100 Firms

The IPA’s 2019 Top 100 Firms recognizes the top U.S.-based accounting firms and is the most comprehensive list of North American public accounting firms available. IPA annually ranks the largest public accounting firms in the U.S. based on participating firm’s net revenues – from the multi-billion-dollar U.S.-based Big 4 to the $5 million firm. Ranking data is captured through IPA’s annual practice management survey and analysis of firms. IPA is the survey leader in data collection for the profession, with more of the largest 500 firms participating than any other survey today and a 92% return rate of participating firms.

For more information and a full list of the Top 100, 200, and 300 firms, visit www.insidepublicaccounting.com.

About Blue and Co.

Blue & Co., LLC is an independent accounting and advisory firm with more than 450 people in 10 offices across Indiana, Ohio, and Kentucky. With almost 50 years of experience, Blue & Co.’s public accounting expertise includes the practice areas of assurance, tax compliance and consulting, healthcare consulting, benefit plan services, valuation and litigation support, and business services. Its industry specializations include manufacturing & distribution, healthcare, construction, nonprofit, technology, financial services organizations, and agribusiness.

For more information, please visit www.blueandco.com.

Share this article

cost segregation study

Unlocking Cash Flow: The Strategic Advantage of Cost Segregation

By Caleb Young, CPA, Manager at Blue & Co. The Advantage of Cost Segregation Studies For Real Estate Investment What if you could significantly increase your cash flow in the first year of […]

Learn More
Original 340B Rebate Model Withdrawn, HRSA Seeks Public Input on Future Rebate Models

Original 340B Rebate Model Withdrawn, HRSA Seeks Public Input on Future Rebate Models

After nearly two months of uncertainty and legal challenges to the initial 340B rebate model pilot program, HRSA is now seeking public input on a future pilot program through March […]

Learn More
PAMA Clinical Lab Reporting Delayed Again: What Hospitals Should Know

PAMA Clinical Lab Reporting Delayed Again: What Hospitals Should Know

Congress has again postponed the next PAMA clinical lab reporting period. Hospitals and outreach labs should still prepare. The new guidelines moved the reporting window to May 1, 2026, through […]

Learn More